Submit Content
Get the latest delivered to your inbox
Privacy Policy

Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. 

    Illumina Included in Just Capital's 2022 List of Top Companies in the U.S. Supporting Healthy Families and Communities Image

    POSTED 

    08-04-22

    Illumina Included in Just Capital's 2022 List of Top Companies in the U.S. Supporting Healthy Families and Communities

    Illumina is honored to be included in JUST Capital 's list of top companies in the US supporting healthy families and communities.
    Breeding a More Resilient Yam in West Africa Image

    POSTED 

    08-02-22

    Breeding a More Resilient Yam in West Africa

    In many tropical countries, yams are known as the “king of crops.” Worldwide, they’re the fourth most utilized root and tuber crop—after potatoes, cassavas, and sweet potatoes—and they feed hundreds of millions of people.
    Illumina Interns Tell All: “You Will Learn Hard and Work Hard” Image

    POSTED 

    07-29-22

    Illumina Interns Tell All: “You Will Learn Hard and Work Hard”

    Ninety-seven interns have joined Illumina’s 12-week US summer internship program. Our interns spend their time fully integrated within an Illumina team, working in either engineering, scientific, or corporate functions.
    Illumina Unveils Its Most Accurate and Comprehensive Secondary Analysis Platform, Boosting Lab Capabilities Image

    POSTED 

    07-28-22

    Illumina Unveils Its Most Accurate and Comprehensive Secondary Analysis Platform, Boosting Lab Capabilities

    Illumina, a global leader in DNA sequencing and array-based technologies, announced today the release of Illumina DRAGEN™ v4.0, its most accurate and comprehensive secondary analysis platform.
    Kathryne Reeves, Illumina's Chief Marketing Officer Among Savoy's 2022 Most Influential Black Executives in Corporate America Image

    POSTED 

    07-26-22

    Kathryne Reeves, Illumina's Chief Marketing Officer Among Savoy's 2022 Most Influential Black Executives in Corporate America

    Illumina is thrilled to announce that Kathryne Reeves, Illumina's Chief Marketing Officer, has been featured among Savoy's 2022 Most Influential Black Executives in Corporate America.
    SD2 Students Receive Illumina STEM Scholars Award Image

    POSTED 

    07-25-22

    SD2 Students Receive Illumina STEM Scholars Award

    Applications for the Illumina/SD2 STEM Scholars Award opened in the Fall, and closed in January with a total of 36 student applications. The scholarship was open to all 10th through 12th grade students in San Diego County.
    Illumina Recognized as a Top-Scoring Company on Disability:IN and American Association of People With Disabilities' Disability Index Image

    POSTED 

    07-22-22

    Illumina Recognized as a Top-Scoring Company on Disability:IN and American Association of People With Disabilities' Disability Index

    Illumina is proud to be a top-scoring company on Disability:IN and American Association of People with Disabilities' Disability Equality Index and recognized as a BestPlaceToWork for Disability Inclusion.
    Illumina Announces Inaugural Illumina Genomics Forum With a Conversation With Former U.S. President Barack Obama Image

    POSTED 

    07-19-22

    Illumina Announces Inaugural Illumina Genomics Forum With a Conversation With Former U.S. President Barack Obama

    Illumina, today announced that former President of the United States Barack Obama will participate in a moderated Q&A conversation at the inaugural Illumina Genomics Forum, the company's global event focused on advancing genomics-driven health.
    Illumina Among First in the World to Receive Approval of Science-Based Net-Zero Target Image

    POSTED 

    07-15-22

    Illumina Among First in the World to Receive Approval of Science-Based Net-Zero Target

    Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced today it is among the first group of companies worldwide to receive approval of its net-zero targets by the Science Based Targets initiative (SBTi)
    Illumina CEO Highlights the Company’s Efforts To Leverage Genomics for Good Image

    POSTED 

    07-08-22

    Illumina CEO Highlights the Company’s Efforts To Leverage Genomics for Good

    We entered 2021 full of hope for a recovery from the pandemic, at the dawn of a new era of genomic medicine, and a recognition of the incredible opportunities for us to rebuild a healthier, more inclusive, and more sustainable global community.
    Illumina logo

    Illumina

    Illumina

    Join today and get the latest delivered to your inbox